Publications by authors named "Shingo Shoji"

Claim this Profile
P
Phase I Study of Rogocekib in Patients with Relapsed or Refractory Hematologic Malignancies.
Hisayuki Yokoyama, Noriko Fukuhara, Koji Ando, Hiroatsu Iida, Takahiro Yamauchi, Shingo Shoji

Blood Adv· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Risk of insulin initiation with sodium-glucose cotransporter-2 inhibitors versus dipeptidyl peptidase-4 inhibitors in patients with type 2 diabetes mellitus: A real-world claims database study in Japan.
Ryo Suzuki, Shingo Shoji, Yoko Yoshinaga, Yoshinori Kosakai, Mami Shintani-Tachi

Diabetes Obes Metab· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Healthcare resource utilization and healthcare costs in patients with type 2 diabetes mellitus initiating sodium-glucose cotransporter 2 inhibitors vs dipeptidyl peptidase-4 inhibitors in Japan: A real-world administrative database analysis.
Atsunori Kashiwagi, Shingo Shoji, Yoshinori Kosakai, Yoko Yoshinaga, Mitsuhiro Rokuda

J Diabetes Investig· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cardiometabolic risk reductions in patients with type 2 diabetes mellitus newly treated with a sodium-glucose cotransporter 2 inhibitor versus a dipeptidyl peptidase-4 inhibitor: A real-world administrative database study in Japan.
Atsunori Kashiwagi, Shingo Shoji, Yoshinori Kosakai, Tadashi Koga, Keiko Asakawa

J Diabetes Investig· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Demographic and clinical characteristics of patients with type 1 diabetes mellitus initiating sodium-glucose cotransporter 2 inhibitors in Japan: A real-world administrative database analysis.
Norio Abiru, Shingo Shoji, Yoshinori Kosakai, Robert Snijder, Keiko Asakawa

Diabetes Res Clin Pract· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reduction in cardiovascular disease events in patients with type 2 diabetes mellitus treated with a sodium-glucose cotransporter 2 inhibitor versus a dipeptidyl peptidase-4 inhibitor: A real-world retrospective administrative database analysis in Japan.
Atsunori Kashiwagi, Shingo Shoji, Satoshi Onozawa, Yoshinori Kosakai, Miina Waratani

J Diabetes Investig· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[A cross-sectional analysis of the health-related quality of life and work productivity in Japanese subjects with self-reported chronic constipation using the National Health and Wellness Survey 2017].
Yoshikazu Kinoshita, Shingo Shoji, Toshihiro Hayashi, Hiroyuki Okumura

Nihon Shokakibyo Gakkai Zasshi· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cost-effectiveness analysis of fidaxomicin for the treatment of Clostridioides (Clostridium) difficile infection in Japan.
Hiroyuki Okumura, Maki Ueyama, Shingo Shoji, Marci English

J Infect Chemother· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Fidaxomicin compared with vancomycin and metronidazole for the treatment of Clostridioides (Clostridium) difficile infection: A network meta-analysis.
Hiroyuki Okumura, Ayako Fukushima, Vanessa Taieb, Shingo Shoji, Marci English

J Infect Chemother· January 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Acute lethal crush-injured rats can be successfully rescued by a single injection of high-dose dexamethasone through a pathway involving PI3K-Akt-eNOS signaling.
Isamu Murata, Kazuya Ooi, Shingo Shoji, Yohei Motohashi, Miwa Kan

J Trauma Acute Care Surg· August 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Insomnia in diabetes].
Shingo Shoji, Yoshihisa Shoji

Nihon Rinsho· August 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lack of association of interleukin-18 gene polymorphisms with susceptibility of Japanese populations to Graves' disease or Graves' ophthalmopathy.
Tokunori Mukai, Yuji Hiromatsu, Michiko Ichimura, Tomoka Fukutani, Hiroo Kaku, Shingo Shoji

Thyroid· March 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Interleukin-13 gene polymorphisms confer the susceptibility of Japanese populations to Graves' disease.
Yuji Hiromatsu, Tomoka Fukutani, Michiko Ichimura, Tokunori Mukai, Hiroo Kaku, Shingo Shoji

J Clin Endocrinol Metab· January 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunohistochemical analysis of bcl-2, Bax and Bak expression in thyroid glands from patients with Graves' disease.
Yuji Hiromatsu, Hiroo Kaku, Tokunori Mukai, Ikuyo Miyake, Tomoka Fukutani, Shingo Shoji

Endocr J· August 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A polymorphism of interferon-gamma gene associated with changes of anti-thyrotropin receptor antibodies induced by antithyroid drug treatment for Graves' disease in Japanese patients.
Tomoka Fukutani, Yuji Hiromatsu, Hiroo Kaku, Ikuyo Miyake, Tokunori Mukai, Shingo Shoji

Thyroid· February 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis